Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2014
12/31/2014CN102772357B 用于持续释放多巴胺受体激动剂的可植入聚合物装置 For the sustained release of dopamine agonist implantable polymeric device
12/31/2014CN102757447B 一种尿素通道蛋白抑制剂及其制备方法与应用 One kind of urea channel protein inhibitor and its preparation method and application
12/31/2014CN102746308B 别嘌醇衍生物及其制备方法和用途 Allopurinol derivatives and their preparation and use
12/31/2014CN102731415B 喹唑啉-4-哌嗪二硫代甲酸酯及其制备方法和用途 Quinazolin-4-piperazine two thioformate its preparation and use
12/31/2014CN102702116B 4-(3-氯-4-甲氧基苯胺基)-6-(3-胺基苯基)喹唑啉类化合物或其药学上可接受的盐和制备方法与应用 4- (3-chloro-4-methoxyanilino) -6- (3-amino-phenyl) quinazoline compound or a pharmaceutically acceptable salt thereof and a preparation method and application
12/31/2014CN102595893B 螺内酰胺衍生物及其用途 Spiro lactam derivatives and their use
12/31/2014CN102574787B 具有潜在的抗癌活性的小分子异戊二烯基半胱氨酸羧基甲基转移酶抑制剂 Small molecule prenyl carboxymethyl cysteine ​​with potential anticancer activity inhibitor
12/31/2014CN102558072B 2-(4-烃基甲酰氧基苯基羰基甲基硫基)嘧啶酮类化合物及其应用 2- (4-formyl-phenyl hydrocarbyl carbonyl methylthio) pyrimidine-based compounds and their Applications
12/31/2014CN102458116B Iap抑制剂 Iap inhibitors
12/31/2014CN102369189B 氟喹诺酮羧酸分子晶体 Fluoroquinolone carboxylic acid molecular crystals
12/31/2014CN102365290B 与含有规定量目标己糖的原料糖不同的糖组成的糖组合物制造方法以及所制造的糖组合物的用途 Uses and raw sugar contains a predetermined amount of different target hexose sugar composition and method of producing the sugar composition of the saccharide composition produced
12/31/2014CN102335166B 含有牛蒡苷元的药物组合物及其用途 Arctigenin containing pharmaceutical compositions and uses thereof
12/31/2014CN102293772B 一种复方注射剂的制备方法及质量控制方法 Preparation method of compound injection and quality control methods
12/31/2014CN102250176B 抗肿瘤抗生素安可霉素及其衍生物 Antitumor antibiotic rapamycin and its derivatives encore
12/31/2014CN102232076B 吡咯并吡嗪基脲激酶抑制剂 Pyrrolopyrazine urea kinase inhibitor
12/31/2014CN102177144B (r)-5-[3-氯-4-(2,3-二羟基-丙氧基)-苯并[z]亚基]-2-([z]-丙基亚胺基)-3-邻甲苯基-噻唑烷-4-酮的晶形 (R) -5- [3- chloro-4- (2,3 - dihydroxy-propoxy) - benzo [z] ylidene] -2 - ([z] - -propylimino) -3 - o-tolyl - thiazolidin-4-one in crystalline form
12/31/2014CN102146107B (s)-2-羟烷基-1,4-二羟基-9,10-蒽醌与糖基缀合物的合成及抗肿瘤活性 Synthesis and antitumor activity (s) -2- hydroxy alkyl-1,4-dihydroxy-9,10-anthraquinone and glycosylated conjugates
12/31/2014CN102137864B 作为选择性11-β-羟基甾族化合物脱氢酶1型抑制剂的稠合吡咯烷并-环丙烷衍生物 As selective 11-β- hydroxy steroid dehydrogenase type 1 inhibitors and fused pyrrolidine - cyclopropane derivative
12/31/2014CN102101858B 雷莫司琼衍生物及其制备方法和用途 Ramosetron derivatives and their preparation and use
12/31/2014CN102056907B 杂环衍生物及其用途 Heterocyclic derivatives and their use
12/31/2014CN102056499B 用于调节脂质代谢的组合物 The composition for regulating lipid metabolism
12/31/2014CN102015651B 作为tlr活性调节剂的化合物和组合物 As the compounds and compositions of active modulators tlr
12/31/2014CN102007118B 吡咯烷酮葡糖激酶激活剂 Pyrrolidone glucokinase activators
12/31/2014CN101951770B Hcv蛋白酶抑制剂和其用途 Hcv protease inhibitors and their uses
12/31/2014CN101951769B Hcv蛋白酶抑制剂和其用途 Hcv protease inhibitors and their uses
12/31/2014CN101862374B 莲子心及其提取物的新用途 New uses lotus heart and extracts
12/30/2014USRE45314 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/30/2014US8921595 Protein Arginine Deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer
12/30/2014US8921569 Rationally improved isoniazid and ethionamide derivatives and activity through selective isotopic substitution
12/30/2014US8921568 Iminosugars and their applications
12/30/2014US8921565 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
12/30/2014US8921563 1-[(4-hydroxypiperidin-4-yl)methyl]pyridin-2(1H)-one derivatives, preparation methods and uses thereof
12/30/2014US8921562 Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
12/30/2014US8921560 Indoles as respiratory syncytial virus antiviral agents
12/30/2014US8921559 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2
12/30/2014US8921556 Process for N-dealkylation of tertiary amines
12/30/2014US8921555 Substituted-1,3,8-triazaspiro[4.5]decane-2,4-diones
12/30/2014US8921547 Modulators of TNF-α signaling
12/30/2014US8921545 Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones
12/30/2014US8921542 Epothilone derivatives
12/30/2014US8921536 HCV vaccines and methods for using the same
12/30/2014US8921533 Glycosylated valproic acid analogs and uses thereof
12/30/2014US8921514 Anti-viral compounds
12/30/2014US8921448 Transfection compositions using amphipathic compounds
12/30/2014US8921429 Biodegradable stealth polymeric particles fabricated using the macromonomer approach by free radical dispersion polymerization
12/30/2014US8921427 Antiseptic alginate preparation
12/30/2014US8921426 Cationic bis-urea compounds as effective antimicrobial agents
12/30/2014US8921425 Treatment of fungal infections
12/30/2014US8921424 Histone deacetylase inhibitors, process for preparation and uses thereof
12/30/2014US8921423 Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid
12/30/2014US8921421 Inhibitors of dimethylarginine dimethylaminohydrolase
12/30/2014US8921419 Triterpenoids and compositions containing the same
12/30/2014US8921418 Controlled release of phenolic opioids
12/30/2014US8921417 Method of treating dyslipidemia using naturally occurring diterpene
12/30/2014US8921416 Dronedarone solid dispersion and preparation method thereof
12/30/2014US8921415 Polymorphs of darunavir
12/30/2014US8921414 Spiroketals
12/30/2014US8921413 β- and γ-diketones and γ-hydroxyketones as WNT/ β-catenin signaling pathway activators
12/30/2014US8921412 C-aryl ansa SGLT2 inhibitors
12/30/2014US8921410 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
12/30/2014US8921409 Combination of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}benzamide and a NMDA receptor antagonist and pharmaceutical compositions containing the same
12/30/2014US8921408 Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof
12/30/2014US8921407 Pyrazole compounds that modulate HSP90 activity
12/30/2014US8921406 5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors
12/30/2014US8921405 Compounds
12/30/2014US8921404 Azole derivatives in the form of lipase and phospholipase inhibitors
12/30/2014US8921401 Pyrazole compounds, compositions and methods for treatment of degenerative diseases and disorders
12/30/2014US8921399 Therapeutic isoxazole compounds
12/30/2014US8921398 N-cyclopropyl-N-piperidinyl-amide derivatives, pharmaceutical compositions and uses thereof
12/30/2014US8921397 Benzofurane-piperidine compounds
12/30/2014US8921396 Crystalline freebase forms of a biphenyl compound
12/30/2014US8921395 Crystalline forms of a biphenyl compound
12/30/2014US8921394 Prolylcarboxypeptidase inhibitors
12/30/2014US8921393 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
12/30/2014US8921392 6-aminoisoquinoline compounds
12/30/2014US8921391 Selective EP4 receptor antagonistic substance for treatment of cancer
12/30/2014US8921390 Medicaments for inhibiting thrombus formation
12/30/2014US8921389 Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase
12/30/2014US8921388 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
12/30/2014US8921387 Injectable flowable composition comprising buprenorphine
12/30/2014US8921386 Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
12/30/2014US8921385 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same
12/30/2014US8921384 Spiro[2.4]heptanes for treatment of flaviviridae infections
12/30/2014US8921383 Thiazolopyrimidine compounds
12/30/2014US8921382 Thiazolo[5,4-d] pyrimidines and their use as agrochemicals
12/30/2014US8921381 Inhibitors of secretion of hepatitis B virus antigens
12/30/2014US8921380 Pyrazolo[1,5-a] pyrimidine compounds as CB1 receptor antagonist
12/30/2014US8921379 Fused ring compound and use thereof
12/30/2014US8921378 Androgen receptor modulating carboxamides
12/30/2014US8921377 Substituted 5-fluoro-1H-pyrazolopyridines and their use
12/30/2014US8921376 Pyrrolopyridines useful as inhibitors of protein kinase
12/30/2014US8921375 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
12/30/2014US8921374 Itraconazole compositions and dosage forms, and methods of using the same
12/30/2014US8921373 Compounds having TRPV1 antagonistic activity and uses thereof
12/30/2014US8921372 Inhibitors of hepatitis C virus
12/30/2014US8921371 Oligomer-protein tyrosine kinase inhibitor conjugates
12/30/2014US8921370 Bicyclo[3.2.1]octyl amide derivatives and uses of same
12/30/2014US8921369 Inhibitors of HCV NS5A
12/30/2014US8921368 Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
12/30/2014US8921367 Use of AMG 900 for the treatment of cancer
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 7860